Stocks
ANI Pharmaceuticals (ANIP) EV/EBITDA US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | 246.3 | 9.52 | 0.61 | 24.4 | 7.83 | 6.86 | ||
| Changes by years, y/y, % | +1 219% | -96% | -94% | +3 931% | -68% | -16.0% | |||
ANI Pharmaceuticals. EV/EBITDA
ANI Pharmaceuticals. EV/EBITDA, changes, %
ANI Pharmaceuticals (ANIP) EV/EBITDA US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| EV/EBITDA | ? | 26.6 | 19.0 | 11.6 | 7.19 | 6.92 | 6.86 | |
| Changes by years, y/y, % | +7 045% | +5 707% | -50% | -71% | -74% | |||
| Changes by quarters, q/q, % | +9% | -29% | -39% | -38% | -4% | |||
